Free Trial
Discover Investing Tools for the A.I EraGet 30 Days Free

Daxor Corporation (NASDAQ:DXR) Short Interest Update

Written by MarketBeat
Updated September 20, 2025
Daxor logo with Medical background

Key Points

  • Daxor Corporation (NASDAQ:DXR) experienced a 30.5% decrease in short interest during August, with total short interest dropping to 38,300 shares.
  • The stock traded down 0.2% to $11.64, with a trading volume of 1,672 shares compared to its average of 7,637 shares.
  • Osaic Holdings Inc. made a new investment in Daxor, acquiring 8,750 shares valued at approximately $86,000, representing about 0.18% ownership in the company.
  • Five stocks to consider instead of Daxor.

Daxor Corporation (NASDAQ:DXR - Get Free Report) saw a significant drop in short interest in August. As of August 31st, there was short interest totaling 38,300 shares, a drop of 30.5% from the August 15th total of 55,100 shares. Based on an average daily trading volume, of 28,200 shares, the short-interest ratio is currently 1.4 days. Approximately 1.9% of the company's stock are sold short. Approximately 1.9% of the company's stock are sold short. Based on an average daily trading volume, of 28,200 shares, the short-interest ratio is currently 1.4 days.

Institutional Investors Weigh In On Daxor

A hedge fund recently bought a new stake in Daxor stock. Osaic Holdings Inc. bought a new position in Daxor Corporation (NASDAQ:DXR - Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 8,750 shares of the company's stock, valued at approximately $86,000. Osaic Holdings Inc. owned 0.18% of Daxor as of its most recent filing with the Securities and Exchange Commission. 1.34% of the stock is owned by institutional investors and hedge funds.

Daxor Stock Up 4.2%

Daxor stock traded up $0.48 during midday trading on Friday, reaching $11.88. The company's stock had a trading volume of 1,247 shares, compared to its average volume of 5,445. Daxor has a fifty-two week low of $6.55 and a fifty-two week high of $11.88. The business has a 50-day simple moving average of $10.53 and a 200-day simple moving average of $9.03.

About Daxor

(Get Free Report)

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions.

Recommended Stories

Should You Invest $1,000 in Daxor Right Now?

Before you consider Daxor, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Daxor wasn't on the list.

While Daxor currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Ride The A.I. Megaboom Cover
7 Stocks to Ride The A.I. Megaboom


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report
Like this article? Share it with a colleague.